Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 355.00
Bid: 350.00
Ask: 360.00
Change: -2.00 (-0.56%)
Spread: 10.00 (2.857%)
Open: 355.00
High: 355.00
Low: 355.00
Prev. Close: 357.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

Fri, 03rd May 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

Deutsche Bank initiates Hikma Pharmaceuticals with 'buy' - target 2,750 pence

----------

Deutsche Bank initiates ConvaTec with 'buy' - target 315 pence

----------

Jefferies cuts Smith & Nephew price target to 1,250 (1,300) pence - 'buy'

----------

Berenberg raises Standard Chartered price target to 1,100 (1,050) pence - 'buy'

----------

Barclays raises Standard Chartered target to 800 (750) pence - 'equal weight'

----------

UBS raises Standard Chartered price target to 840 (810) pence - 'buy'

----------

Barclays raises Land Securities price target to 730 (700) pence - 'overweight'

----------

Barclays raises 3i Group price target to 3,050 (2,815) pence - 'overweight'

----------

Berenberg raises National Grid price target to 1,150 (1,100) pence - 'hold'

----------

Barclays raises Beazley price target to 920 (910) pence - 'overweight'

----------

Berenberg raises SSE price target to 2,100 (2,000) pence - 'buy'

----------

Bank of America raises Shell price target to 3,400 (3,300) pence - 'buy'

----------

UBS raises Shell price target to 2,900 (2,700) pence - 'neutral'

----------

JPMorgan raises Smurfit Kappa price target to 4,200 (4,100) pence - 'overweight'

----------

Deutsche Bank initiates Airtel Africa with 'buy' - target 160 pence

----------

FTSE 250

----------

Deutsche Bank initiates Indivior with 'buy' - target 2,350 pence

----------

Deutsche Bank initiates Helios Towers with 'buy' - target 265 pence

----------

Berenberg raises Trainline price target to 460 (450) pence - 'buy'

----------

Barclays raises Lancashire price target to 800 (790) pence - 'equal weight'

----------

Barclays cuts Hiscox price target to 1,320 (1,340) pence - 'equal weight'

----------

Barclays cuts Hammerson price target to 30 (32) pence - 'overweight'

----------

Barclays cuts Great Portland price target to 385 (442) pence - 'underweight'

----------

Barclays cuts British Land to 'equal weight' (overweight) - price target 405 (432) pence

----------

Jefferies cuts AJ Bell to 'hold' (buy) - price target 361 (390) pence

----------

Deutsche Bank initiates IP Group with 'buy' - target 100 pence

----------

Deutsche Bank initiates Syncona with 'buy' - target 205 pence

----------

Deutsche Bank initiates Spire Healthcare with 'buy' - target 320 pence

----------

JPMorgan cuts Dowlais price target to 100 (104) pence - 'neutral'

----------

JPMorgan cuts Pennon Group price target to 710 (740) pence - 'neutral'

----------

Jefferies cuts Tyman to 'hold' (buy) - price target 400 (360) pence

----------

Deutsche Bank initiates Pets At Home with 'buy' - target 370 pence

----------

Deutsche Bank initiates Telecom Plus with 'buy' - target 2,950 pence

----------

SMALL CAP

----------

Peel Hunt raises Johnson Service Group to 'buy' (add) - price target 168 (154) pence

----------

Deutsche Bank initiates Oxford BioMedica with 'hold' - target 250 pence

----------

Deutsche Bank initiates Oxford Nanopore with 'buy' - target 190 pence

----------

Deutsche Bank initiates MaxCyte with 'hold' - target 330 pence

----------

Deutsche Bank initiates Alliance Pharma with 'buy' - target 85 pence

----------

Deutsche Bank initiates Advanced Medical Solutions with 'buy' - target 250 pence

----------

Deutsche Bank initiates IQE with 'buy' - target 55 pence

----------

Deutsche Bank initiates Iomart with 'buy' - target 185 pence

----------

Deutsche Bank Gamma Communications with 'buy' - target 2,250 pence

----------

Deutsche Bank initiates CVS Group with 'buy' - target 1,400 pence

----------

Barclays cuts NewRiver price target to 87 (90) pence - 'overweight'

----------

RBC cuts SIG price target to 32 (33) pence - 'sector perform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
Today 14:27

UK shareholder meetings calendar - next 7 days

Wednesday 5 June 
Albion Technology & General VCT PLCAGM
Capital LtdAGM
Centrica PLCAGM
Churchill China PLCAGM
DigitalBox PLCAGM
Distribution Finance Capital Holdings PLCAGM
Gem Diamonds LtdAGM
Great Western Mining Corp PLCAGM
Gulf Marine Services PLCAGM
LungLife AI IncAGM
Nostrum Oil & Gas PLCAGM
Thursday 6 June 
Argo Blockchain PLCAGM
Camellia PLCAGM
Downing Renewables & Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Fevertree Drinks PLCAGM
Inspecs Group PLCAGM
Invesco Perpetual UK Smaller Companies Investment Trust PLCAGM
Kavango Resources PLCAGM
Kore Potash PLCAGM
Kosmos Energy LtdAGM
Rogue Baron PLCAGM
S&U PLCAGM
S4 Capital PLCAGM
Tan Delta Systems PLCAGM
Friday 7 June 
Property Franchise Group PLCAGM
Trident Royalties PLCAGM
TruSpine Technologies PLCAGM
Monday 10 June 
Aterian PLCAGM
Griffin Mining LtdAGM
Lok'n Store Group PLCGM re takeover by Shurgard
Onward Opportunities LtdAGM
Oxford Nanopore Technologies PLCAGM
Pan African Resources PLCGM re capital reduction
Tuesday 11 June 
Ebiquity PLCAGM
Flowtech Fluidpower PLCAGM
MaxCyte IncAGM
Mobico Group PLCAGM
Newbury Racecourse PLCAGM
Nightcap PLCGM re fundraise
Phoenix Digital Assets PLCGM re up to GBP33.7 million fundraise
Tirupati Graphite PLCGM requisitioned by Walpole St Andrews Nominees
Tortilla Mexican Grill PLCAGM
Tufton Oceanic Assets LtdEGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 May 2024 21:51

IN BRIEF: MaxCyte inks deal with Legend Biotech for tech supply

MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Inks strategic platform license agreement with Legend Biotech Corp, a firm focused in cell therapy. Under the terms of the agreement, Legend Biotech will get a non-exclusive worldwide license to use MaxCyte's Flow Electroporation technology and ExPERT platform in connection with the research, clinical development and commercialisation of cell-based therapeutical products. Accordingly, MaxCyte will be allowed to receive annual licensing fees and milestones from Legend during clinical development.

Read more
8 May 2024 12:45

MaxCyte reports strong first quarter

(Sharecast News) - MaxCyte reported total first-quarter revenue of $11.3m in an update on Wednesday, making for a 32% increase compared to the same period in 2023.

Read more
8 May 2024 09:46

MaxCyte shares rise amid double-digit revenue increase

(Alliance News) - MaxCyte Inc on Wednesday reported a jump in its first quarter revenue, which it said was driven by its core business sales.

Read more
30 Apr 2024 14:38

UK earnings, trading statements calendar - next 7 days

Wednesday 1 May 
Anexo Group PLCFull Year Results
Cambridge Cognition Holdings PLCFull Year Results
Computacenter PLCTrading Statement
Georgia Capital PLCQ1 Results
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
Thursday 2 May 
Endeavour Mining PLCQ1 Results
First Tin PLCTrading Statement
Hiscox LtdTrading Statement
International Personal Finance PLCTrading Statement
Kerry Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
Melrose Industries PLCTrading Statement
NAHL Group PLCFull Year Results
Reach PLCTrading Statement
Shell PLCQ1 Results
Smiths News PLCHalf Year Results
Smurfit Kappa Group PLCTrading Statement
Spectris PLCTrading Statement
Standard Chartered PLCQ1 Results
TI Fluid Systems PLCQ1 Results
Friday 3 May 
InterContinental Hotels Group PLCTrading Statement
Mondi PLCTrading Statement
Trainline PLCFull Year Results
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Arecor Therapeutics PLCFull Year Results
BP PLCQ1 Results
Ebiquity PLCFull Year Results
IWG PLCTrading Statement
Kosmos Energy LtdQ1 Results
MaxCyte IncQ1 Results
Trident Royalties PLCTrading Statement
Vaalco Energy IncQ1 Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Apr 2024 15:19

TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Mar 2024 12:04

MaxCyte reports strong fourth quarter as full-year revenues fall

(Sharecast News) - Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15.7m on Wednesday, up 26% on the same period in 2022.

Read more
13 Mar 2024 11:54

IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%

MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Net loss widens to USD37.9 million in 2023 from USD23.6 million in 2022, as revenue declines by 6.7% to USD41.3 million from 44.3 million. Core business revenue falls by 25% to USD29.8 million from USD39.6 million, but strategic platform license programme-related revenue more than doubles to USD11.5 million from USD4.6 million. In the fourth quarter alone, revenue is USD15.7 million, up 26% from USD12.4 million a year before, as core business revenue falls by 32% but SPL revenue more than quadruples.

Read more
5 Mar 2024 20:43

EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Mar 2024 16:06

UK earnings, trading statements calendar - next 7 days

Wednesday 6 March 
Breedon Group PLCFull Year Results
Capita PLCFull Year Results
ConvaTec Group PLCFull Year Results
DS Smith PLCTrading Statement
Galliford Try Holdings PLCHalf Year Results
Greencoat Renewables PLCFull Year Results
Ibstock PLCFull Year Results
Lancashire Holdings LtdFull Year Results
Legal & General Group PLCFull Year Results
Netcall PLCHalf Year Results
Nexxen International LtdFull Year Results
Nichols PLCFull Year Results
Quilter PLCFull Year Results
Rathbones Group PLCFull Year Results
Ricardo PLCFull Year Results
Spirent Communications PLCFull Year Results
TClarke PLCFull Year Results
Tullow Oil PLCFull Year Results
CLS Holdings PLCFull Year Results
Thursday 7 March 
Admiral Group PLCFull Year Results
Aviva PLCFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Coats Group PLCFull Year Results
Darktrace PLCHalf Year Results
Elementis PLCFull Year Results
Entain PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Harbour Energy PLCFull Year Results
ITV PLCFull Year Results
Kier Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Nexus Infrastructure PLCFull Year Results
PageGroup PLCFull Year Results
Physiomics PLCHalf Year Results
Rentokil Initial PLCFull Year Results
Robert Walters PLCFull Year Results
Spirax-Sarco Engineering PLCFull Year Results
TT Electronics PLCFull Year Results
Tyman PLCFull Year Results
Friday 8 March 
Informa PLCFull Year Results
Just Group PLCFull Year Results
LMS Capital PLCFull Year Results
Stelrad Group PLCFull Year Results
Monday 11 March 
HgCapital Trust PLCFull Year Results
Mincon Group PLCFull Year Results
MTI Wireless Edge LtdFull Year Results
Tuesday 12 March 
BATM Advanced Communications LtdFull Year Results
Costain Group PLCFull Year Results
Domino's Pizza Group PLCFull Year Results
Fonix Mobile PLCHalf Year Results
Foresight Solar Fund LtdFull Year Results
Genuit PLCFull Year Results
H&T Group PLCFull Year Results
Hill & Smith PLCFull Year Results
MaxCyte IncFull Year Results
Persimmon PLCFull Year Results
Synthomer PLCFull Year Results
Target Healthcare REIT PLCHalf Year Results
TI Fluid Systems PLCFull Year Results
TP ICAP Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
5 Mar 2024 13:01

MaxCyte flags lower 2023 revenue, flat 2024 growth

(Sharecast News) - Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41.1m and $41.3m, down from $44.3m in 2022.

Read more
30 Jan 2024 13:58

IN BRIEF: MaxCyte signs licencing deal with cell therapy company Wugen

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Signs strategic platform licence with Wugen Inc, a US-based clinical-stage biotech company developing off-the-shelf cell therapies for the treatment of hematological and solid cancer tumour malignancies. Wugen's lead program is evaluating WU-CART-007, a cell therapy for the treatment of relapsed or refractory T-cell acute lymphoblastic leukaemia. Under the terms of the agreement, Wugen gains non-exclusive clinical and commercial rights to use MaxCyte's unique Flow electroporation technology and its trademarked ExPERT research platform. In exchange, MaxCyte will receive annual licence fees and programme-related revenue, although precise transaction details were not provided.

Read more
29 Jan 2024 17:56

IN BRIEF: MaxCyte chief scientific officer leaves firm

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Announces departure of Cenk Sumen as chief scientific officer, but he will remain on advisory board.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.